Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 4 Interventional

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

ClinicalTrials.gov ID: NCT07611214

Public ClinicalTrials.gov record NCT07611214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PRESERVE: A Multi-Center Phase 4 Study of the Efficacy and Safety of LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab at Inducing Rapid Renal Response in Patients With Lupus Nephritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical study is to assess the efficacy and safety of LUPKYNIS® in combination with belimumab, obinutuzumab or anifrolumab at inducing rapid renal response in patients with lupus nephritis (LN).

Study identification

NCT ID
NCT07611214
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Aurinia Pharmaceuticals Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 21, 2026
Primary completion
Mar 1, 2029
Completion
Mar 1, 2029
Last update posted
Aug 2, 2026

2026 – 2029

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Purushotham & Akther Kotha MD, Inc. La Mesa California 91942 Recruiting
Valerius Medical Group & Research Center of Greater Long Beach, Inc. Los Alamitos California 90720 Recruiting
Western Nephrology & Metabolic Bone Disease, PC Arvada Colorado 80002 Recruiting
Swati Shah MD Rheumatology, LLC Jacksonville Florida 32257 Recruiting
Vida Clinical Research Kissimmee Florida 34741 Recruiting
Life Clinical Trials Margate Florida 33063 Recruiting
CTR Oakwater Orlando Florida 32806 Recruiting
Parris and Associates Rheumatology Lawrenceville Georgia 30044 Recruiting
Accurate Clinical Research, Inc. Lake Charles Louisiana 70605 Recruiting
Arthritis and Rheumatism Associates Rockville Maryland 20850 Recruiting
Kansas City Physician Partners Kansas City Missouri 64151 Recruiting
University of Nevada Las Vegas Las Vegas Nevada 89102 Recruiting
Sahni Rheumatology & Therapy West Long Branch New Jersey 07764 Recruiting
Buffalo Rheumatology and Medicine, PLLC Orchard Park New York 14217 Recruiting
Arthritis and Osteoporosis Consultants of the Carolinas Charlotte North Carolina 28202 Recruiting
Joint and Muscle Research Institute Charlotte North Carolina 28204 Recruiting
Rheumatic Disease Associates, Ltd. Willow Grove Pennsylvania 19090 Recruiting
Dunes Clinical Research Dakota Dunes South Dakota 57049 Recruiting
West Tennessee Research Institute Jackson Tennessee 38305 Recruiting
Novel Research LLC Bellaire Texas 77401 Recruiting
Liberty Research Center Dallas Texas 75230 Recruiting
Texas Arthritis Center El Paso Texas 79902 Recruiting
Integrative Rheumatology of South Texas Harlingen Texas 78550 Recruiting
Northwest Houston Arthritis Center Houston Texas 77090 Recruiting
Texas Tech University Health Science Center Lubbock Texas 79430 Recruiting
Texas Rheumatology Research Institute, LLC Plano Texas 75024 Recruiting
Nephrology Leaders and Associates, PLLC Van Vleck Texas 77482 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07611214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07611214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →